Tarsus Pharmaceuticals, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 40
Rang # Quantité totale PI 35 009
Note d'activité PI 2,7/5.0    65
Rang # Activité PI 10 987
Symbole boursier TARS (nasdaq)
ISIN US87650L1035
Capitalisation 2,000M  (USD)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

14 10
3 3
4 6
0
 
Dernier brevet 2025 - Isoxazoline parasiticide formula...
Premier brevet 2018 - Methods for treating ocular demo...
Dernière marque 2024 - MIGHT OVER MITES
Première marque 2021 - TARSUS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Providing diagnostic and medical information relating to ophthalmic diseases; providing diagnosti...
Invention Isoxazoline parasiticide formulations and methods for treating blepharitis. Disclosed herein are...
P/S Ophthalmic preparations; preparations for destroying parasites; pharmaceutical preparations for t...
P/S Ophthalmic preparations; preparations for destroying parasites; pharmaceutical preparations for ...
P/S Providing diagnostic and medical information relating to ophthalmic diseases; providing diagnost...
Invention Isoxazoline parasiticide formulations and methods for treating blepharitis. Disclosed herein are ...
2023 P/S Providing business administration information and assistance to patients and healthcare professio...
Invention Systemic isoxazoline parasiticides for vector-borne and viral disease treatment or prophylaxis. ...
Invention Methods for treating ocular demodex using spinosad formulations. Disclosed herein are methods fo...
2022 Invention Demodex using lotilaner formulations. Disclosed herein are methods for treating or preventing oph...
Invention Methods for treating demodex blepharitis using lotilaner formulations. Disclosed herein are metho...
Invention Pharmaceutical compositions for demodex related blepharitis and eyelid crusting. Formulation of ...
2021 P/S Pharmaceutical research and development; providing medical and scientific research information in...
2020 Invention Systemic isoxazoline parasiticides for vector-borne and viral disease treatment or prophylaxis. P...
Invention Systemic isoxazoline parasiticides for vector-borne and viral disease treatment or prophylaxis. D...
2018 Invention Methods for treating ocular demodex using isoxazoline parasiticide formulations. Disclosed herein...